Patents by Inventor Xiaojin Liao

Xiaojin Liao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INTERFERON-BASED DISEASE TREATMENT METHOD
    Publication number: 20230285509
    Abstract: The invention relates to the field of biomedicine. In particular, the present invention relates to an interferon-based method for treating a disease, comprising intermittently administering an interferon-based therapeutic agent to a subject, where the disease is for example a viral infection or a cancer.
    Type: Application
    Filed: July 22, 2020
    Publication date: September 14, 2023
    Applicants: XIAMEN AMOYTOP BIOTECH CO., LTD., BIOSTEED GENE TRANSFORMATION TECH. CO., LTD.
    Inventors: LI SUN, Weidong ZHOU, Xiaojin LIAO, Lu ZHUANG, Ruoyi HE, Ting ZHOU, Lingying ZENG, Meihua YANG, Shiyuan WANG, Jiehua ZHENG, Linzhong ZHANG
  • INTERFERON-BASED CANCER TREATMENT METHOD AND PHARMACEUTICAL COMPOSITION
    Publication number: 20230270824
    Abstract: The present invention relates to the field of biomedicine. Disclosed herein is interferon-based method and pharmaceutical combination for treating cancer. In particular, the present invention relates to an interferon-based method for treating cancer, comprising i) intermittently administering an interferon-based therapeutic agent, and ii) administering an additional anticancer agent, preferably, Gemcitabine, to a subject. The present invention also relates to a pharmaceutical combination for use in said method.
    Type: Application
    Filed: April 14, 2023
    Publication date: August 31, 2023
    Inventors: LI SUN, WEIDONG ZHOU, XIAOJIN LIAO, LU ZHUANG, RUOYI HE, TING ZHOU, LINGYING ZENG, MEIHUA YANG, SHIYUAN WANG, JIEHUA ZHENG, LINZHONG ZHANG
  • Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof
    Patent number: 9840546
    Abstract: The growth hormone with high biological activity modified by the double-stranded polyethylene glycol at a single site and the preparation method thereof are provided. The PEGylated growth hormone has a higher biological activity and a longer half-life than the unmodified growth hormone. The composition comprising the PEGylated growth hormone is useful in the treatment of the growth or development disorder such as growth hormone deficiency, Turner syndrome etc.
    Type: Grant
    Filed: April 3, 2008
    Date of Patent: December 12, 2017
    Assignee: Biosteed Gene Expression Tech. Co., Ltd.
    Inventors: Weidong Zhou, Xiaojin Liao, Li Sun, Linzhong Zhang, Qingsong Lu, Shiye Shen, Lishan Yang, Defang Zhang, Huihuang Lin, Ping Zhang